Drug makers and regulators are taking steps towards transparency, but is it enough?

Dissecting a ligand into smaller fragments can provide a strategy for analyzing the role of key functional groups in a protein-ligand interaction.

It is well established that the use of nanotechnology in medicine and more specifically drug delivery is spreading rapidly.

The techniques of laser diffraction and automated particle imaging support the fast, cost-effective development of nasal spray products, simultaneously providing the data required for regulatory compliance. This paper examines their application.

Abusers are finding ways to circumvent current abuse-deterrent measures, leaving companies in need of new strategies.

Farid and her team have developed a range of software tools to help biopharma companies make decisions on the best manufacturing processes.

Several companies are faced with recall woes thanks to insects, dodgy closures and broken tablets.

The biopharma industry has a long way to go before it’s ready to embrace superior manufacturing models. Why?

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.

The December issue will feature our inaugural Innovation Awards, recognising the most exciting new technologies of 2015.